Svitlana A Husieva

Svitlana A Husieva

Auto-generated profile, based on publicly available information

Svitlana A Husieva

Українська військово-медична академія

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2023 in Ukrainian Journal of Military Medicine
Verified
Journal Article
Open access
PDF file
SGS. A. Guseva
S. A. Guseva
GOG. V. Osyodlo
G. V. Osyodlo
YGYa. P. Goncharov
Ya. P. Goncharov
ALA. V. Lysak
A. V. Lysak
ODO. G. Dyrda
O. G. Dyrda
OAO. Ya. Antonyuk
O. Ya. Antonyuk
Вступ. Тромботична тромбоцитопенічна пурпура (ТТП) (хвороба Мошковица) є рідкісним захворюванням. ТТП характеризується тромбоцитопенією і мікроангіопатичною анемією (МАГА) різного ступеня тяжкості. Характерним для ТТП є діагностична пентада: МАГА, тромбоцитопенія, неврологічна симптоматика, ураження нирок і лихоманка. Патогенез цього захворювання включає порушення регуляції активності фактора Віллебранда внаслідок значного дефіциту Disintegrin and Metalloprotease with ThromboSpondin, type I repeat, member 13 (ADAMTS13), який виявлений у більшості пацієнтів з вродженою і набутою ТТП. ТТП у дорослих осіб характеризується прогресуючим перебігом, незворотним ураженням нирок, прогресуючим ураженням центральної нервової системи, ішемією міокарду нерідко з летальним наслідком. Мета роботи - на прикладі клінічних випадків продемонструвати лікарям-клініцистам важливість вчасного розпізнавання клінічних ознак тромботичної тромбоцитпенічної пурпури (ТТП), а також захворювань, які можуть спровокувати виникнення цього синдрому. Матеріали та методи. Використані перідичні медичні видання, історії хвороби пацієнтів, матеріали науково-практичних конференцій. Методи дослідження: історичний, бібліографічний, системного підходу, статистичний, аналітичний, узагальнення. Результати. У статті детально проаналізовано дані про рідкісне захворювання - тромботичну тромбоцитопенічну пурпуру (ТТП), патогенез цього захїворювання. Описані два клінічних випадків ТТП. У першому клінічному випадку діагноз базувався на наявності тромбоцитопенії, МАГА, ураження центральної нервової системи, нирок і лихоманці. Діагноз був встановлений вчасно. Після лікування (замісні інфузії плазми) стан пацієнтки значно покращився. Атиповий перебіг захворювання ( кліеічний випадок № 2) спричинив об’єктивні труднощі для своєчасного прижиттєвого діагностування злоякісної пухлини передміхурової залози з метастазами. Лише після проведення гістологічного дослідження секційного матеріалу було виявлено множинні метастатичні ураження кісток скелету, лімфатичних вузлів, легень. Висновки. ТТП є смертельно небезпечним захворюванням, яке не має специфічних симптомів. У кожному випадку вперше виявленої тромбоцитопенії необхідно ставити питання про виключення ТТП за допомогою діагностичної діади, довести його неімунний характер і обов'язково детально вивчити морфологію еритроцитів для виявлення шистозоцитозу. При відсутності інших видимих причин для тромбоцитопенії і неімунної гемолітичної анемії діагноз ТТП можна вважати обгрунтованим і негайно починати лікування із застосуванням плазмаферезу і трансфузій свіжозамороженої плазми. Раннє призначення адекватної терапії дозволяє уникнути життєво небезпечного ураження органів - мішеней.

27 June 2024 in Military Medicine
Verified
Journal Article
Closed access
PDF file
SHSvitlana A Husieva
Svitlana A Husieva
GOGalyna V Osyodlo
Galyna V Osyodlo
AHAndrii V Husiev
Andrii V Husiev
KSKyrylo V Savichan
Kyrylo V Savichan
The article presents a clinical case of peculiarities of clinical manifestations, diagnostic and therapeutic approaches of undiagnosed chronic myeloproliferative disease, on the background of which Budd-Chiari syndrome (BCS) developed. The results of clinical course, examination, and treatment of a patient with BCS as a manifestation of the hidden course of primary myelofibrosis with the presence of somatic mutation (V617F) in Janus-tyrosine kinase-2 (JAK2) gene in myeloid cells are presented. Standard clinical and laboratory examinations, and cytomorphologic and histologic examination of bone marrow were used. The diagnosis of BCS was confirmed by ultrasound (US) Doppler examination of the portal system vessels. Symptomatic therapy resulted in insignificant positive results. The analysis of this clinical case showed that the development of BCS was due to a chronic myeloproliferative disease that was not diagnosed before the development of thrombosis. Hepatic vein thrombosis was accompanied by the development of fulminant cytolytic syndrome. Along with symptomatic therapy, patient K., female, 32 years old, underwent transjugular intrahepatic portosystemic shunting 1 month after the first symptoms of BCS appeared, which contributed to a significant clinical effect. Seven years after the installation of 4 transjugular intrahepatic portosystemic shunts, the patient’s condition remains satisfactory. The uniqueness of this clinical case lies in the presence of 2 serious diseases at the same time: myeloproliferative pathology (primary myelofibrosis) JAK2-positive variant and BCS. Timely diagnosis of both hematological diseases and their complication in the form of hepatic vein thrombosis with fulminant cytolytic syndrome allowed timely prescription of adequate treatment with a good clinical response.

4 March 2025 in Military Medicine
Verified
Journal Article
Closed access
SHSvitlana A Husieva
Svitlana A Husieva
GOGalyna V Osyodlo
Galyna V Osyodlo
IGIan P Goncharov
Ian P Goncharov
OAOlena Ya Antonyuk
Olena Ya Antonyuk
AHAndrii V Husiev
Andrii V Husiev
VCVlad Yu Cherevko
Vlad Yu Cherevko
Introduction: During the full-scale war in Ukraine, the number of military personnel suffering from combat injuries with the development of anemia significantly increased. The work aimed to generalize and study the clinical and hematological characteristics of anemia in service members who received gunshot and blast injuries during combat operations. Materials and Methods: We examined 264 servicemen within 6 months (main group). They took part in hostilities and received gunshot and shrapnel wounds accompanied by blood loss. The control group consisted of 87 practically healthy service members. Complete blood test was performed on an automatic hematology analyser ABX Micros ES 60 of the company Horiba ABX. We determined the level of ferritin using the enzyme immunoassay method ELISA, the concentration of serum iron using the photometric method, and C-reactive protein (CRP) using the immunoturbidimetric latex method (quantitatively). The studies’ results were processed using variational statistics. For each group of patients, the arithmetic mean (M), the standard deviation (Ϭ), and the error of the arithmetic mean (m) were calculated. We used the statistical processing package STATISTICA 10 (Statsoft Inc.). Results: Isolated injuries accounted for 50.89%, injuries to two or more anatomical areas—49.11%, injuries to limbs and large joints—30.6%, chest—14.66%, abdominal cavity—21.9%, and polytrauma—32.84%. All patients had blood loss, but its degree was not countable. The number of erythrocyte mass transfusions ranged from 2 to 7 (3.5 ± 0.7 on average). A total of 39.42% of victims were delivered in a severe condition, and 60.58% in a moderate condition. We divided the patients into the groups: 1st group (n = 60) where the blood was tested after in 1 month after injury, 2nd (n = 42)—2 months, 3rd (n = 37), 4th (n = 31), 5th (n = 26), and 6th (n = 24) in 3, 4, 5, and 6 months. We observed an initial increase in the number of leukocytes and platelets, and a decrease in the levels of erythrocytes, hemoglobin, MCV, and MCH, an increase in the absolute number of granulocytes and monocytes, and a decrease in the number of lymphocytes. In all, 7.9% of patients were diagnosed with severe anemia, 44.7% with moderate, and 40.4% with mild. The ferritin level exceeded the control group’s results almost three times, while the iron content in the blood serum was significantly reduced. The hemoglobin level did not normalize within six months in most service members with anemia (because of severity or complications of the injuries and multiple surgeries). The CRP was elevated for 6 months after injury. Correlation analysis confirmed a positive relationship between the level of hemoglobin, the number of leukocytes, and the level of CRP. Conclusions: We view combat anemia as more than a hematology issue. It needs prompt, coordinated care from various fields. Interventions may include blood transfusions, surgery, and correcting iron levels. We can decrease the concentration of pro-inflammatory cytokines through anti-inflammatory therapy. Additionally, possible adrenergic modulation can promote erythropoiesis.

21 November 2023 in Military Medicine
Verified
Journal Article
Closed access
PDF file
GOGalyna V Osyodlo
Galyna V Osyodlo
SHSvitlana A Husieva
Svitlana A Husieva
SSSvitlana V Svicharova
Svitlana V Svicharova
KSKyrylo V Savichan
Kyrylo V Savichan
The article analyses data on the occurrence of hematological abnormalities in severe acute respiratory syndrome 2 infection. Among these hematological abnormalities, the majority of patients develop a hypercoagulable state associated with thromboembolic complications and poor prognosis. Approximately one-third of patients with severe acute respiratory syndrome 2 infection are diagnosed with mild to severe thrombocytopenia. Another hematological autoimmune disease observed in patients with coronavirus disease 2019 is autoimmune hemolytic anemia. A clinical case with the development of autoimmune hemolytic anemia in the setting of coronavirus infection was described. The diagnosis was based on the presence of anemia, reticulocytosis, a significant decrease in haptoglobin levels, and a positive antiglobulin test (Coombs test). Given the comorbidity, the risks of adverse effects of severe coronavirus disease were high, despite this, it was possible to achieve clinical and hematological remission of autoimmune hemolytic anemia by prescribing pathogenetic therapy with anti-CD-20 monoclonal antibody (rituximab), recombinant erythropoietin and glucocorticoid hormones. This clinical case demonstrates the possibility of successful treatment of patients with severe hemolytic anemia. Special attention should be paid to the discrepancy between the severity of the condition and objective data. This case demonstrates the need for a more in-depth approach to each patient with anemia associated with coronavirus disease infection, namely, in the presence of anemic syndrome, it is imperative to include a full range of laboratory tests.

30 June 2023 in Ukrainian Journal of Military Medicine
Verified
Journal Article
Open access
PDF file
GOG. V. Osyodlo
G. V. Osyodlo
SHS. A. Husieva
S. A. Husieva
YGYa. P. Goncharov
Ya. P. Goncharov
TGT. S. Gruzieva
T. S. Gruzieva
OAO. Ya. Antonyuk
O. Ya. Antonyuk
Introduction. This study aims to assess the organization and state of providing medical care to patients with COVID-19, to identify existing problems and challenges, to identify the main directions for improving the system of providing medical care to patients, to highlight the main approaches to hospitalization of different contingents and age groups, and to apply preventive strategies to patients with high cardiometabolic risk. Materials and methods. Research methods: a systematic approach, statistical, content analysis, structural and logical analysis. We used statistical data on the results of treatment of hospitalized patients with COVID-19 at the National Military Medical Clinical Center "Main Military Clinical Hospital" in 2020-2021 and, in particular, the sample group (n=146) of patients with severe or mild and medium course of COVID-19 to estimate the prevalence of risk factors of unfavorable course among them. Results. A statistically significant difference was found between the frequency of obesity (40.5% vs. 19.8%, p=0.031), between the frequency of detection of patients with an increased body mass index over 25 kg/m2 (89.2% vs. 51.5%, p< 0.001) and the median value of the body mass index (25.1 kg/m2 and 27.7 kg/m2, p<0.001) in groups of different severity of the coronavirus disease. There was no statistically significant difference between the prevalence of previously known diabetes in the groups (p=0.107). In our opinion, the implementation of national registry of patients with diabetes would improve the efficiency of providing medical care to patients with the coronavirus disease due to the personalized assessment of the individual risk of a severe course of the coronavirus disease. Conclusion. It was found that the treatment results, the frequency of adverse effects of COVID-19 in patients were correlated with the Polish and American population, increased with the age of patients, and in the presence of concomitant comorbidity, particularly in the fact of metabolic disorders. The frequency of metabolic disorders in patients with adverse consequences of COVID-19 increased with age and in the presence of concomitant comorbidities. It is proposed to expand the indications for hospitalization for coronavirus disease in patients with diabetes, regardless of the degree of compensation, especially if they have excess body weight or obesity, atherosclerotic diseases of the heart and blood vessels (in the presence of an acute myocardial infarction or a cerebrovascular event in the anamnesis), until the development in those patients of hypoxemic states (SpO2 less than 93%). To improve the effectiveness of treatment results for this category of patients, it is recommended to approve the legislative framework and allocate funding to create a national register of patients with diabetes.

27 November 2025 in Military Medicine
Verified
Journal Article
Closed access
PDPavlo O Dubovetskyi
Pavlo O Dubovetskyi
SHSvitlana A Husieva
Svitlana A Husieva
IGIan P Goncharov
Ian P Goncharov
VOVitalii M Orlov
Vitalii M Orlov
Wartime conditions present major challenges to the timely diagnosis and management of severe aplastic anemia (SAA). We describe 3 previously healthy military service members who developed idiopathic SAA during active duty. In all 3 patients, no chronic illnesses were documented in the medical records, and no specific toxin exposures or prior hepatitis were recorded. All experienced a gradual onset of cytopenias accompanied by hemorrhagic symptoms, initial misclassification as immune thrombocytopenia or myelodysplastic syndrome, and war-related delays to definitive therapy. Each required prolonged transfusion support and broad-spectrum antibiotics for neutropenic complications. Two patients received immunosuppressive therapy (antithymocyte globulin plus cyclosporine A) four to 5 months after diagnosis, while the youngest underwent urgent allogeneic bone marrow transplantation. Despite severe logistical constraints, all survived the acute phase but remained transfusion-dependent at discharge. These cases underscore the need to strengthen medical logistics and ensure early access to specialized hematologic care to improve SAA outcomes during wartime.